Opus Genetics, Inc.: accounts_receivable
| Value | {"amount": 0, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Opus Genetics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f2e26a4-4ace-42c1-b3ea-6029546d8634
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-21-028115Retrieved: 2026-08-19T12:00:05.893770+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001228627/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f2e26a4-4ace-42c1-b3ea-6029546d8634
History
- no predecessors — first report